Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › dronabinol

dronabinol

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of dronabinol

24 trials tracked of dronabinol: 5 in phase 3 or 4 and 2 with published results. The most-cited published study has 47 citations.

24Trials tracked
5Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 3 Phase 2 7 Phase 1 8 Other / NA 4
  1. Phase 3 Combined Pharmacotherapy for Cannabis Dependency Completed · 47 cited
  2. Phase 3 Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors Completed · 17 cited
  3. Phase 4 Effects of Pregnancy-associated Hormones on THC Metabolism in Women Completed
  4. Phase 4 Cannabinoid Control of Fear Extinction Neural Circuits in Humans Completed
  5. Phase 3 Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer Completed
  6. Phase 2 Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain Completed
Show 18 more trials
  1. Phase 2 Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea Completed
  2. Phase 2 Dronabinol Treatment for Marijuana Addiction Completed
  3. Phase 2 Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome Completed
  4. Phase 2 Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS) Completed
  5. Phase 2 Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal Completed
  6. Phase 2 Marinol in Trichotillomania or Obsessive Compulsive Disorder Completed
  7. Phase 1 A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas Completed
  8. Phase 1 Developing a Mobile Method to Measure THC-induced Impairment Completed
  9. Phase 1 Individual Differences in Drug Response Completed
  10. Phase 1 Ph1 Marinol Interaction Study - Part 2 - 1 Completed
  11. Phase 1 Cannabis and Schizophrenia: Self-Medication and Agonist Treatment Completed
  12. Phase 1 Behavioral Pharmacology of THC and Alpha-pinene Completed
  13. Phase 1 Age-Related Effects of THC Completed
  14. Phase 1 Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? Completed
  15. N/A Individual Differences in the Response to Drugs Completed
  16. N/A Prevention of Postoperative Nausea and Vomiting (PONV) in Surgical Patients Completed
  17. N/A Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder Completed
  18. N/A Using Imaging to Assess Effects of THC on Brain Activity Completed

Showing the 24 most-cited and recently-updated of 24 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
FDA Approves Marinol (dronabinol) for AIDS-Related Anorexia and Chemotherapy-Induced Nausea/Vomiting
Oncology FDA Approval
FDA Approves Marinol (dronabinol) for AIDS-Related Anorexia and Chemotherapy-Induced Nausea/Vomiting FDA approves a new drug called Marinol to help with AIDS-related weight loss and chemotherapy nausea
The FDA has approved Marinol (dronabinol) for two indications in adults: anorexia associated with weight loss in patients with AIDS, and nau…
The FDA approved Marinol to treat AIDS-related weight loss and severe chemotherapy nausea that standard treatments couldn't control.
FDA Mar 31, 2026